| Esophageal Squamous Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 64show all (up to 200) |
|---|
| → investigated in trials for | Cisplatinsmall_molecule 47 trials (17 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 40 trials (18 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 28 trials (11 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall_molecule 27 trials (11 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal_antibody 26 trials (14 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 21 trials (7 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal_antibody 20 trials (10 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 17 trials (11 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 16 trials (8 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 16 trials (5 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 14 trials (6 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 14 trials (6 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 14 trials (6 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 13 trials (10 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Esophageal Squamous Cell Carcinoma | 13 | Observed | clinicaltrials | graph → |